Crossref
The prevalence of menopausal level of follicle-stimulating hormone in peri-menopausal breast cancer patients aged between 45 and 60 years
Asian Journal of Oncology · 25.04.2026 · 12 · 10
DOI: 10.25259/asjo_36_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Oncology, online erschienen am 25.04.2026. Verfasst von Atia Saif. Die Arbeit nennt 5 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Saif, A. (2026). The prevalence of menopausal level of follicle-stimulating hormone in peri-menopausal breast cancer patients aged between 45 and 60 years. Asian Journal of Oncology, 12, 10. https://doi.org/10.25259/asjo_36_2025
Vancouver
Saif A. The prevalence of menopausal level of follicle-stimulating hormone in peri-menopausal breast cancer patients aged between 45 and 60 years. Asian Journal of Oncology. 2026;12:10. doi:10.25259/asjo_36_2025
BibTeX
@article{Saif2026,
author = {Saif, Atia},
title = {The prevalence of menopausal level of follicle-stimulating hormone in peri-menopausal breast cancer patients aged between 45 and 60 years},
journal = {Asian Journal of Oncology},
year = {2026},
volume = {12},
pages = {10},
doi = {10.25259/asjo_36_2025}
}
EUVIMED